文献速递腹部CT

基于深度学习的双能CT 40-keV虚拟单能图像重建用于评估低强化肝转移瘤

Deep learning-based image reconstruction of 40-keV virtual monoenergetic images of dual-energy CT for the assessment of hypoenhancing hepatic metastasis.
PubMed 文献 · Eur Radiol · 2022-04-05

这项回顾性研究纳入131例门静脉期接受双能CT检查的患者,比较线性融合模拟100-kVp图像、标准40-keV虚拟单能图像与深度学习模型重建的40-keV虚拟单能图像对低强化肝转移瘤的评估价值。结果显示DLM 40-keV VMI的病灶-肝脏对比噪声比、病灶 conspicuity 和诊断可接受度均优于另两种图像,对246个肝转移瘤的检测效能高于标准40-keV VMI(0.852 vs 0.822,p=0.012),与100-kVp图像无显著差异(0.852 vs 0.842,p=0.31)。

要点

  • DLM 40-keV VMI的病灶-肝脏CNR为8.25±3.23,高于标准40-keV VMI的6.05±2.38和100-kVp的5.99±2.00。
  • DLM 40-keV VMI病灶conspicuity为4.3(4.0-4.7),优于标准40-keV VMI的3.7(3.7-4.0)和100-kVp的3.7(3.3-4.0)。
  • DLM 40-keV VMI对肝转移瘤检测的figure of merit为0.852,高于标准40-keV VMI的0.822(p=0.012),与100-kVp的0.842无显著差异(p=0.31)。

核心结论

  • DLM 40-keV VMI较线性融合图像提供更好的图像质量和相当的诊断效能,用于检测低强化肝转移瘤。

研究设计与样本

  • 回顾性研究纳入131例因肝转移瘤监测行门静脉期对比增强双能CT(80-kVp和150-kVp加锡滤过)的患者,重建线性融合模拟100-kVp图像、标准40-keV VMI和经厂商无关DLM后处理的40-keV VMI,由三名独立评估者评估,以两名独立放射科医师共识为参考标准。

诊断标准与关键数值

  • DLM 40-keV VMI病灶-肝脏CNR为8.25±3.23,标准40-keV VMI为6.05±2.38,100-kVp为5.99±2.00(p<0.001);病灶conspicuity分别为4.3(4.0-4.7)、3.7(3.7-4.0)、3.7(3.3-4.0)(p<0.001);诊断可接受度分别为4.3(4.0-4.3)、3.0(2.7-3.3)、4.0(4.0-4.3)(p<0.001)。

临床应用与阅片要点

  • DLM 40-keV VMI较标准40-keV VMI提高病灶检测效能(figure of merit 0.852 vs 0.822,p=0.012),与100-kVp图像检测效能无显著差异(0.852 vs 0.842,p=0.31)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the diagnostic value of deep learning model (DLM) reconstructed dual-energy CT (DECT) low-keV virtual monoenergetic imaging (VMI) for assessing hypoenhancing hepatic metastases.

METHODS: This retrospective study included 131 patients who underwent contrast-enhanced DECT (80-kVp and 150-kVp with a tin filter) in the portal venous phase for hepatic metastasis surveillance. Linearly blended images simulating 100-kVp images (100-kVp), standard 40-keV VMI images (40-keV VMI), and post-processed 40-keV VMI using a vendor-agnostic DLM (i.e., DLM 40-keV VMI) were reconstructed. Lesion conspicuity and diagnostic acceptability were assessed by three independent reviewers and compared using the Wilcoxon signed-rank test. The contrast-to-noise ratios (CNRs) were also measured placing ROIs in metastatic lesions and liver parenchyma. The detection performance of hepatic metastases was assessed by using a jackknife alternative free-response ROC method. The consensus by two independent radiologists was used as the reference standard.

RESULTS: DLM 40-keV VMI, compared to 40-keV VMI and 100-kVp, showed a higher lesion-to-liver CNR (8.25 ± 3.23 vs. 6.05 ± 2.38 vs. 5.99 ± 2.00), better lesion conspicuity (4.3 (4.0-4.7) vs. 3.7 (3.7-4.0) vs. 3.7 (3.3-4.0)), and better diagnostic acceptability (4.3 (4.0-4.3) vs. 3.0 (2.7-3.3) vs. 4.0 (4.0-4.3)) (p < 0.001 for all). For lesion detection (246 hepatic metastases in 68 patients), the figure of merit was significantly higher with DLM 40-keV VMI than with 40-keV VMI (0.852 vs. 0.822, p = 0.012), whereas no significant difference existed between DLM 40-keV VMI and 100-kVp (0.852 vs. 0.842, p = 0.31).

CONCLUSIONS: DLM 40-keV VMI provided better image quality and comparable diagnostic performance for detecting hypoenhancing hepatic metastases compared to linearly blended images.

KEY POINTS: • DLM 40-keV VMI provides a superior image quality compared with 40-keV or 100-kVp for assessing hypoenhancing hepatic metastasis. • DLM 40-keV VMI has the highest CNR and lesion conspicuity score for hypoenhancing hepatic metastasis due to noise reduction and structural preservation. • DLM 40-keV VMI provides higher lesion detectability than standard 40-keV VMI (p = 0.012).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lee, Lee, Yoon, et al. Deep learning-based image reconstruction of 40-keV virtual monoenergetic images of dual-energy CT for the assessment of hypoenhancing hepatic metastasis. Eur Radiol. 2022. PMID: 35380228. doi:10.1007/s00330-022-08728-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。